* Lunit set to launch Lunit INSIGHT DBT in the European market * Lunit seeks FDA clearance, pavi...
* Five posters from Lunit and collaborators demonstrate important progress in the development of ...
* Lunit to establish new subsidiary, Lunit Europe Holdings, to expand sales network acrossEurope ...
* First-ever randomized controlled trial regarding deep learning-based AI in radiology provides s...
* Dubai Academic Health Corporation (DAHC) Dubai Hospital to modernize its Breast Cancer Diagnost...
* Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows...
* Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune ...
* Lunit signed a software license agreement with the Hospital Israelita Albert Einstein,Latin Ame...
* Recent study suggests that AI-based x-ray interpretation algorithms may be an efficient means t...
* Lunit signed a global distribution agreement to provide its AI-based radiology solutions for cl...
* Lunit becomes first software as a medical device (SaMD) company in APAC to become MDR CE and UK...
* Lunit's INSIGHT MMG solution has been selected for mammogram screening in Australia's BreastScr...
* Lunit to present three abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immun...
* 7 oral presentations and 1 e-poster highlighting Lunit's most up-to-date research on its AI sol...
* Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-onl...
* Lunit participates in the 20th Asian Oceanian Congress of Radiology and 78th Annual Meeting of ...
* Joint study with Massachusetts General Hospital proves that Lunit's AI-powered chest x-ray anal...
* Lunit participated in the "Indonesia AI Healthcare Course," organized by South Korean Ministry ...
* Lunit to present five posters at ESMO 2022 featuring the company's AI-biomarker platform * St...
* Lunit's AI solution for mammography received a class 2 medical device license from the Taiwan F...
